We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India
Price data last checked 149 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 24 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 582 days • 582 data points (No recent data available)
Price Distribution
Price distribution over 582 days • 1 price levels
Price Analysis
Most common price: £495 (582 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 582 days
Product Specifications
- Format
- paperback
- ASIN
- B00E1FEJL6
- Domain
- Amazon UK
- Release Date
- 19 June 2013
- Listed Since
- 23 July 2013
Similar Products You Might Like
The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics
The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments for US Zip Codes
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
The 2013-2018 Outlook for Respiratory Care Equipment and Supplies in India
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
The 2013-2018 Outlook for Bronchial Dilator and Anti-Asthmatic Pharmaceutical Preparations in India
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
The 2013-2018 Outlook for Respiratory Care Equipment and Supplies in Europe
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
Chronic Obstructive Pulmonary Disease - Contemporary and Consummate Management of a Systemic Disorder
IntechOpen
The 2013-2018 Outlook for Tobacco and Non-Tobacco Cigarettes in India
